NAS:COEP (USA)
Â
Ordinary Shares
$
0.28
+0.0048 (+1.74%)
11:09 PM EST
Business Description
Coeptis Therapeutics Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US19207A1088
Share Class Description:
COEP: Ordinary SharesDescription
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.56 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -22.7 | |||||
3-Year EPS without NRI Growth Rate | -23.9 | |||||
3-Year FCF Growth Rate | -22.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.34 | |||||
9-Day RSI | 42.81 | |||||
14-Day RSI | 44.12 | |||||
6-1 Month Momentum % | -57.27 | |||||
12-1 Month Momentum % | -81.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.6 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 0.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20 | |||||
Shareholder Yield % | -44.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -467.04 | |||||
ROA % | -216.12 | |||||
ROIC % | -339.64 | |||||
ROC (Joel Greenblatt) % | -22207.76 | |||||
ROCE % | -329.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.34 | |||||
Price-to-Tangible-Book | 2.34 | |||||
EV-to-EBIT | -0.74 | |||||
EV-to-Forward-EBIT | -2.93 | |||||
EV-to-EBITDA | -0.79 | |||||
EV-to-Forward-EBITDA | -2.93 | |||||
EV-to-FCF | -1.59 | |||||
Price-to-Net-Current-Asset-Value | 5.62 | |||||
Earnings Yield (Greenblatt) % | -135.14 | |||||
FCF Yield % | -71.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:COEP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coeptis Therapeutics Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.54 | ||
Beta | 0 | ||
Volatility % | 64.04 | ||
14-Day RSI | 44.12 | ||
14-Day ATR ($) | 0.028319 | ||
20-Day SMA ($) | 0.293913 | ||
12-1 Month Momentum % | -81.63 | ||
52-Week Range ($) | 0.2303 - 1.6199 | ||
Shares Outstanding (Mil) | 37.12 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Coeptis Therapeutics Holdings Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Coeptis Therapeutics Holdings Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Coeptis Therapeutics Holdings Inc Frequently Asked Questions
What is Coeptis Therapeutics Holdings Inc(COEP)'s stock price today?
The current price of COEP is $0.28. The 52 week high of COEP is $1.62 and 52 week low is $0.23.
When is next earnings date of Coeptis Therapeutics Holdings Inc(COEP)?
The next earnings date of Coeptis Therapeutics Holdings Inc(COEP) is 2024-08-09 Est..
Does Coeptis Therapeutics Holdings Inc(COEP) pay dividends? If so, how much?
Coeptis Therapeutics Holdings Inc(COEP) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |